X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ORCHID PHARMA LTD UNICHEM LAB/
ORCHID PHARMA LTD
 
P/E (TTM) x -276.9 0.2 - View Chart
P/BV x 2.0 0.2 981.5% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 UNICHEM LAB   ORCHID PHARMA LTD
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
ORCHID PHARMA LTD
Sep-13
UNICHEM LAB/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs320194 164.9%   
Low Rs22135 631.4%   
Sales per share (Unadj.) Rs167.2276.5 60.5%  
Earnings per share (Unadj.) Rs12.0-79.2 -15.1%  
Cash flow per share (Unadj.) Rs16.9-43.5 -39.0%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs117.053.9 217.0%  
Shares outstanding (eoy) m90.8870.45 129.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.60.4 390.6%   
Avg P/E ratio x22.6-1.4 -1,564.5%  
P/CF ratio (eoy) x16.0-2.6 -606.2%  
Price / Book Value ratio x2.32.1 108.9%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m24,5788,067 304.7%   
No. of employees `0005.22.8 185.3%   
Total wages/salary Rs m2,4872,527 98.4%   
Avg. sales/employee Rs Th2,928.36,956.1 42.1%   
Avg. wages/employee Rs Th479.4902.5 53.1%   
Avg. net profit/employee Rs Th209.4-1,993.0 -10.5%   
INCOME DATA
Net Sales Rs m15,19519,477 78.0%  
Other income Rs m110407 27.1%   
Total revenues Rs m15,30519,884 77.0%   
Gross profit Rs m1,7881,103 162.2%  
Depreciation Rs m4522,519 17.9%   
Interest Rs m345,227 0.6%   
Profit before tax Rs m1,413-6,236 -22.7%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m326-125 -260.2%   
Profit after tax Rs m1,087-5,580 -19.5%  
Gross profit margin %11.85.7 207.8%  
Effective tax rate %23.12.0 1,148.8%   
Net profit margin %7.2-28.7 -25.0%  
BALANCE SHEET DATA
Current assets Rs m6,42611,014 58.3%   
Current liabilities Rs m3,91732,060 12.2%   
Net working cap to sales %16.5-108.1 -15.3%  
Current ratio x1.60.3 477.5%  
Inventory Days Days6895 71.3%  
Debtors Days Days7734 229.4%  
Net fixed assets Rs m7,41029,440 25.2%   
Share capital Rs m182705 25.8%   
"Free" reserves Rs m10,4542,043 511.8%   
Net worth Rs m10,6363,800 279.9%   
Long term debt Rs m49,018 0.0%   
Total assets Rs m15,25846,510 32.8%  
Interest coverage x42.9-0.2 -22,222.9%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x1.00.4 237.8%   
Return on assets %7.3-0.8 -966.2%  
Return on equity %10.2-146.9 -7.0%  
Return on capital %13.6-3.7 -364.0%  
Exports to sales %24.137.9 63.7%   
Imports to sales %4.922.6 21.9%   
Exports (fob) Rs m3,6667,378 49.7%   
Imports (cif) Rs m7524,406 17.1%   
Fx inflow Rs m5,2987,513 70.5%   
Fx outflow Rs m05,649 0.0%   
Net fx Rs m5,2981,865 284.2%   
CASH FLOW
From Operations Rs m6831,682 40.6%  
From Investments Rs m-1,316-9,860 13.3%  
From Financial Activity Rs m5926,644 8.9%  
Net Cashflow Rs m-40-1,535 2.6%  

Share Holding

Indian Promoters % 50.1 32.3 155.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 4.6 328.3%  
FIIs % 3.0 3.3 90.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 31.7 55.3 57.3%  
Shareholders   20,176 84,811 23.8%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   FULFORD INDIA  VENUS REMEDIES  IPCA LABS  WOCKHARDT LTD.  AUROBINDO PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Idea Cellular Plunges 6%(12:30 pm)

After opening the day flat share markets in India are trading on a dull note and are presently trading marginally below the dotted line.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jun 25, 2018 03:15 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS